KPV (LYS-PRO-VAL)
Also known as
KPV (LYS-PRO-VAL) is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.
Evidence
Animal or in-vitro only
Risk band
Known AEs, monitoring advised
Research goals
Summary
KPV (Lys-Pro-Val) is a tripeptide corresponding to the C-terminal fragment of the endogenous hormone alpha-melanocyte-stimulating hormone (alpha-MSH), studied chiefly for its anti-inflammatory properties. No source abstracts were provided in this dataset, and the available signals show no PubMed records, no registered clinical trials, and no FDA record for KPV as an administered therapeutic. Evidence for KPV as a human therapeutic is therefore not established here; any claims about benefits would be speculative and cannot be grounded in the supplied literature. This entry should be treated as preliminary pending interventional human data.
No indexed peer-reviewed sources for this entry yet.
For educational purposes only.